[HTML][HTML] Cocaine enhances HIV-1 transcription in macrophages by inducing p38 MAPK phosphorylation

C Swepson, A Ranjan, M Balasubramaniam… - Frontiers in …, 2016 - frontiersin.org
Cocaine is a commonly used illicit drug among HIV-1 infected individuals and is known to
increase HIV-1 replication in permissive cells including PBMCs, CD4+ T cells, and …

[PDF][PDF] Cocaine Enhances HIV-1 Transcription in Macrophages by Inducing p38 MAPK Phosphorylation

C Swepson, A Ranjan, M Balasubramaniam… - core.ac.uk
Cocaine is a commonly used illicit drug among HIV-1 infected individuals and is known to
increase HIV-1 replication in permissive cells including PBMCs, CD4+ T cells, and …

Cocaine Enhances HIV-1 Transcription in Macrophages by Inducing p38 MAPK Phosphorylation

C Swepson, A Ranjan… - Frontiers in …, 2016 - pubmed.ncbi.nlm.nih.gov
Cocaine is a commonly used illicit drug among HIV-1 infected individuals and is known to
increase HIV-1 replication in permissive cells including PBMCs, CD4 (+) T cells, and …

Cocaine Enhances HIV-1 Transcription in Macrophages by Inducing p38 MAPK Phosphorylation.

C Swepson, A Ranjan, M Balasubramaniam… - Frontiers in …, 2016 - europepmc.org
Cocaine is a commonly used illicit drug among HIV-1 infected individuals and is known to
increase HIV-1 replication in permissive cells including PBMCs, CD4+ T cells, and …

[HTML][HTML] Cocaine Enhances HIV-1 Transcription in Macrophages by Inducing p38 MAPK Phosphorylation

C Swepson, A Ranjan, M Balasubramaniam… - Frontiers in …, 2016 - ncbi.nlm.nih.gov
Cocaine is a commonly used illicit drug among HIV-1 infected individuals and is known to
increase HIV-1 replication in permissive cells including PBMCs, CD4+ T cells, and …

Cocaine Enhances HIV-1 Transcription in Macrophages by Inducing p38 MAPK Phosphorylation.

C Swepson, A Ranjan, M Balasubramaniam… - Frontiers in …, 2016 - europepmc.org
Cocaine is a commonly used illicit drug among HIV-1 infected individuals and is known to
increase HIV-1 replication in permissive cells including PBMCs, CD4+ T cells, and …